Astera Labs, Inc. $ALAB Shares Newly Purchased by Howard Capital Management LLC

Howard Capital Management LLC purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 3,123 shares of the company’s stock, valued at approximately $1,112,000.

Other large investors have also modified their holdings of the company. Greenleaf Trust increased its stake in shares of Astera Labs by 1.8% during the 2nd quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock worth $966,000 after purchasing an additional 36 shares in the last quarter. Parkside Financial Bank & Trust raised its position in shares of Astera Labs by 74.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock worth $46,000 after purchasing an additional 41 shares during the last quarter. Glenmede Trust Co. NA lifted its stake in Astera Labs by 2.7% in the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after buying an additional 51 shares in the last quarter. Keating Financial Advisory Services Inc. purchased a new stake in Astera Labs in the 2nd quarter valued at approximately $25,000. Finally, Integrated Wealth Concepts LLC lifted its stake in Astera Labs by 0.7% in the 2nd quarter. Integrated Wealth Concepts LLC now owns 7,006 shares of the company’s stock valued at $3,384,000 after buying an additional 52 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on ALAB shares. Jefferies Financial Group increased their target price on Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Bank of America boosted their price target on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a report on Tuesday, June 23rd. Weiss Ratings raised Astera Labs from a “hold (c)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. TD Cowen reduced their price objective on Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research report on Wednesday, August 5th. Finally, Northland Securities downgraded Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Friday, October 9th. Eleven equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and a consensus price target of $348.33.

Astera Labs Price Performance

Astera Labs stock opened at $285.82 on Friday. The stock has a market capitalization of $49.59 billion, a P/E ratio of 141.50 and a beta of 3.68. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48. The firm’s 50-day moving average is $314.86 and its two-hundred day moving average is $297.01.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s revenue was up 104.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts forecast that Astera Labs, Inc. will post 2.70 EPS for the current year.

Insider Activity

In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief operating officer directly owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. The trade was a 7.49% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the stock in a transaction on Wednesday, October 7th. The stock was sold at an average price of $376.06, for a total value of $3,382,283.64. Following the transaction, the director directly owned 2,648 shares in the company, valued at approximately $995,806.88. This represents a 77.25% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 408,558 shares of company stock valued at $127,306,034 in the last 90 days. Insiders own 10.40% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.